Stemedica Stock

stemedica.comHealthcareFounded: 2005Funding to Date: $82.12MM

Stemedica Cell Technologies is a clinical-stage biopharmaceutical company focused on the development and commercialization of progenitor cell and protein therapeutics for underserved medical conditions.

Register for Details

For more details on financing and valuation for Stemedica, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Stemedica.

Register Today

Team

Management Team

Craig Carlson
Chief Executive Officer
Roger Howe Ph.D
Chairman and Co-Founder
Maynard Howe Ph.D
Co-Founder, Vice Chairman & Chief Executive Officer
Nikolai Tankovich MD
President, Board Member and Chief Medical Officer
Alex Kharazi Ph.D
Chief Technology Officer
Lev Verkh Ph.D
Chief Regulatory and Clinical Development Officer

Board Members

Gary Petrucci
Maynard Howe Ph.D
Nikolai Tankovich MD
Sergey Leshkov
William Maloney MD
Byung-Geon Rhee Ph.D
Green Cross Holdings
Neal Matheson
Richard Mejia Jr.
Simon Guo
Anthony Marlon MD
Guochao Liu
Dirk O'Hara JD
Roger Howe Ph.D

Other companies like Stemedica in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.6B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$296.3MM
Sector
Last Round Est. Valuation
$4.8B